Our news

Lhasa Limited is pleased to announce the release of new data to the Vitic Elemental Impurities database. This pre-competitive data sharing initiative facilitates anonymous sharing of analytical data on the levels of trace elements in excipients.   

Lhasa Limited is excited to announce the latest update to the Vitic Complex Nitrosamines database. This pre-competitive data sharing initiative promotes the anonymous exchange of genetic toxicology data on structurally complex nitrosamines, primarily Ames data.

Lhasa Limited is delighted to announce the release of new pharmaceutical excipient data to our Vitic Excipients database.   This pre-competitive data sharing initiative facilitates anonymous sharing of excipient and vehicle toxicity data, providing members with proprietary formulation information to establish safe limits for pharmaceutical excipients while strengthening regulatory submissions.

Improving offerings across the chemical, biotechnology, pharmaceutical, and most notably, the cosmetics industry. Lhasa is delighted to announce the acquisition of Molecular Networks GmbH and Altamira, LLC.

Lhasa Limited is delighted to announce a new partnership with CTR Scientific, marking a joint commitment to advancing chemical safety assessments in Mexico.

Lhasa Limited is delighted to announce the release of new data to the Vitic Aromatic Amines database.   This pre-competitive data sharing initiative facilitates anonymous sharing of Ames data on primary aromatic amines, enabling the refinement of structure-activity relationships (SARs), and the development of improved predictive tools.

Lhasa Limited is pleased to announce the release of new data to the Vitic AI/PDE database.   This pre-competitive data sharing initiative facilitates anonymous sharing of AI/PDE data from pharmaceutical organisations.

Lhasa Limited is excited to announce a significant enhancement to Sarah Nexus, with the introduction of a new chromosome damage prediction model.

Lhasa Limited is pleased to announce the release of the Vitic 2024.1 database, supporting organisations leading the way in the pharmaceutical, cosmetic, and agrochemical industries, with their chemical risk assessments.

Lhasa Limited is thrilled to announce the launch of Kaptis 2. Kaptis is an in silico solution that is supporting organisations to more efficiently evaluate compound carcinogenic potential, whilst building more ethical and environmentally friendly assessments.